Nobel Prize winner Demis Hassabis thinks human trials will happen soon Clinical trials of the first drugs designed with the ...

Called AlphaFold 3, the new AI software represents a major update and expansion of capabilities beyond Google DeepMind’s previous AlphaFold 2 system. Researchers from the companies published a ...

Among the most important aspects of this story is AlphaFold, the artificial intelligence and foundation model platform developed by Google DeepMind and Isomorphic Labs, both Alphabet companies.

Google DeepMind and EMBL’s freely available AlphaFold2 has had a big impact on research into the role of proteins in disease since its launch in 2021 and is already being used to develop new ...